DIMENSIONAL FUND ADVISORS LP

Position in PYXS — Pyxis Oncology, Inc.

CIK 354204 AUSTIN, TX

Position in PYXS

as of Mar 31, 2026 · filed May 7, 2026 Compact

Position Value

$37,830

-$19,745 QoQ

Shares Held

25,912

-48.2% QoQ

Ownership

0.041%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#42

of 78 holders

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 31.344550787280024.ToString("F0")% Shared 33.9263661623958.ToString("F0")% None 34.72908305032417.ToString("F0")%

Healthcare · as of Mar 31, 2026

DIMENSIONAL FUND ADVISORS LP holds $5,003,215,874 across 223 Biotechnology names. PYXS ranks #213 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	989,342	$441,780,774
2	REGN	Regeneron Pharmaceuticals, Inc.	513,060	$396,410,676
3	JAZZ	Jazz Pharmaceuticals plc	1,895,215	$358,290,394
4	BMRN	Biomarin Pharmaceutical Inc	3,802,930	$214,827,514
5	ROIV	Roivant Sciences Ltd.	7,475,866	$207,081,486
6	INCY	Incyte Corp	1,975,544	$185,938,199
7	EXEL	Exelixis, Inc.	4,299,597	$184,409,714
8	HALO	Halozyme Therapeutics, Inc.	2,079,827	$134,419,216

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$37,830	25,912	-48.2%	Shares	Sole	2026-05-07
2025-12-31	$57,575	50,066	+37.1%	Shares	Sole	2026-02-12
2025-09-30	$81,065	36,516	0.0%	Shares	Sole	2025-11-12
2025-06-30	$40,166	36,516	0.0%	Shares	Sole	2025-08-12
2025-03-31	$35,785	36,516	-67.1%	Shares	Sole	2025-05-13
2024-12-31	$173,238	111,051	+35.5%	Shares	Sole	2025-02-13
2024-09-30	$300,741	81,946	+0.0%	Shares	Sole	2024-11-07
2024-06-30	$271,200	81,934	-19.5%	Shares	Sole	2024-08-09
2024-03-31	$433,709	101,810	0.0%	Shares	Sole	2024-05-10
2023-12-31	$183,257	101,810	-33.8%	Shares	Sole	2024-02-07
2023-09-30	$306,003	153,771	+779.2%	Shares	Sole	2023-11-09
2023-06-30	$44,773	17,490	+44.7%	Shares	Sole	2023-08-09
2023-03-31	$48,468	12,087	—	Shares	Sole	2023-05-12
No filing history on record for this holder in this stock.